Cargando…

Failure of Ciprofloxacin Therapy in the Treatment of Community-Acquired Acute Pyelonephritis caused by In-Vitro Susceptible Escherichia coli Strain Producing CTX-Type Extended-Spectrum β-Lactamase

While carbapenems are the drug of choice to treat extended-spectrum-β-lactamase (ESBL)-producing strains, some alternative carbapenem-sparing regimens are suggested for antibiotic stewardship. We experienced a case of ciprofloxacin treatment failure for acute pyelonephritis caused by an apparently s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seok, Hyeri, Cha, Min Kyeong, Kang, Cheol-In, Cho, Sun Young, Kim, So Hyun, Ha, Young Eun, Chung, Doo Ryeon, Peck, Kyong Ran, Song, Jae-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312905/ https://www.ncbi.nlm.nih.gov/pubmed/30600660 http://dx.doi.org/10.3947/ic.2018.50.4.357

Ejemplares similares

Epidemiology of Ciprofloxacin Resistance and Its Relationship to Extended-Spectrum β-Lactamase Production in Proteus mirabilis Bacteremia
por: Sohn, Kyung Mok, et al.
Publicado: (2011)

Clinical and Molecular Epidemiology of Community-Onset Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli over a 6-Year Period
por: Kang, Cheol-In, et al.
Publicado: (2013)

Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing Escherichia coli infections
por: Park, So Yeon, et al.
Publicado: (2017)

Factors Associated with Acute Community-Acquired Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli
por: Romero Nieto, Mónica, et al.
Publicado: (2021)

2408. Delayed Appropriate Antimicrobial Therapy Does Not Affect the Clinical Outcome of Patients With Acute Pyelonephritis by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
por: Kim, Si-Ho, et al.
Publicado: (2018)

Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producing Klebsiella pneumoniae Bacteremia in Cancer Patients
por: Nham, Eliel, et al.
Publicado: (2020)

Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea
por: Cheong, Hae Suk, et al.
Publicado: (2016)

CTX-M β-Lactamases in Escherichia coli from Community-acquired Urinary Tract Infections, Cambodia
por: Ruppé, Etienne, et al.
Publicado: (2009)

The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli
por: Wu, Na, et al.
Publicado: (2014)

Native valve endocarditis due to extended spectrum β-lactamase producing Klebsiella pneumoniae
por: Jung, Hyun-Ae, et al.
Publicado: (2014)

Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
por: Coque, Teresa M., et al.
Publicado: (2008)

CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of Escherichia coli from Korea
por: Song, Wonkeun, et al.
Publicado: (2009)

Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase–Producing Escherichia coli Infections in Patients with Pyelonephritis, United States
por: Talan, David A., et al.
Publicado: (2016)

Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial -Escherichia coli infection in China
por: Shi, Huiqing, et al.
Publicado: (2015)

Comparing the Synergistic and Antagonistic Interactions of Ciprofloxacin and Levofloxacin Combined with Rifampin against Drug-Resistant Staphylococcus aureus: A Time–Kill Assay
por: Kang, Yu Ri, et al.
Publicado: (2023)

Escherichia coli Producing CTX-M-2 β-Lactamase in Cattle, Japan
por: Shiraki, Yutaka, et al.
Publicado: (2004)

CTX-M β-Lactamase Production and Virulence of Escherichia coli K1
por: Dubois, Damien, et al.
Publicado: (2009)

CTX-M Extended-spectrum β-Lactamases, Washington State
por: Kim, Seonghan, et al.
Publicado: (2007)

Community-Acquired, Extended-Spectrum β-Lactamase-Producing and Extensively Drug-Resistant Escherichia coli in a 28-Year-Old Pyelonephritis Patient Lacking Risk Factors
por: Evins, Connor W., et al.
Publicado: (2021)

Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae
por: Park, Ga Eun, et al.
Publicado: (2021)

Bacteriuria With CTX-M-8 Extended-Spectrum β-Lactamase–Producing Escherichia coli in a Patient With Incomplete Kawasaki Disease
por: Kamijo, Kaori, et al.
Publicado: (2019)

International clones of extended‐spectrum β‐lactamase (CTX‐M)‐producing Escherichia coli in peri‐urban wild animals, Brazil
por: de Carvalho, Marcelo P. N., et al.
Publicado: (2020)

Molecular Epidemiology and Characteristics of CTX-M-55 Extended-Spectrum β-Lactamase-Producing Escherichia coli From Guangzhou, China
por: Zeng, Shihan, et al.
Publicado: (2021)

Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15
por: Park, Sun Hee, et al.
Publicado: (2012)

CTX-M–Type β-Lactamases Affect Community Escherichia coli Treatment, Greece
por: Pournaras, Spyros, et al.
Publicado: (2004)

First Report of Group CTX-M-9 Extended Spectrum Beta-Lactamases in Escherichia coli Isolates from Pediatric Patients in Mexico
por: Merida-Vieyra, Jocelin, et al.
Publicado: (2016)

Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase–Producing Escherichia coli ST410 in the United Kingdom
por: Timofte, Dorina, et al.
Publicado: (2016)

Corrigendum: Molecular Epidemiology and Characteristics of CTX-M-55 Extended-Spectrum β-Lactamase-Producing Escherichia coli From Guangzhou, China
por: Zeng, Shihan, et al.
Publicado: (2022)

Prevalence of Multidrug-Resistant CTX-M Extended Spectrum Beta-Lactamase-Producing Escherichia coli From Different Bovine Faeces in China
por: Wei, Xiaojuan, et al.
Publicado: (2022)

Studies on Virulence and Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Isolates and Therapeutic Effect of Fosfomycin in Acute Pyelonephritis Mice
por: Zhang, Lingchun, et al.
Publicado: (2022)

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131
por: Al-Agamy, Mohamed H, et al.
Publicado: (2014)

CTX-M β-lactamase–producing Escherichia coli in Long-term Care Facilities, France
por: Kassis-Chikhani, Najiby, et al.
Publicado: (2004)

Characterization of AmpC, CTX-M and MBLs types of β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli producing Extended Spectrum β-lactamases in Kerman, Iran
por: Mansouri, Shahla, et al.
Publicado: (2014)

Acute pyelonephritis in a horseshoe kidney
por: Kim, Hyun Ah, et al.
Publicado: (2013)

Characterization of Two New CTX-M-25-Group Extended-Spectrum β-Lactamase Variants Identified in Escherichia coli Isolates from Israel
por: Vervoort, Jascha, et al.
Publicado: (2012)

CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals
por: Bialvaei, Abed Zahedi, et al.
Publicado: (2016)

Novel blaCTX-M variants and genotype-phenotype correlations among clinical isolates of extended spectrum beta lactamase-producing Escherichia coli
por: Ramadan, Ahmed A., et al.
Publicado: (2019)

High rates of CTX-M group-1 extended-spectrum β-lactamases producing Escherichia coli from pets and their owners in Faisalabad, Pakistan
por: Abbas, Ghazanfar, et al.
Publicado: (2019)

Corrigendum: Prevalence of multidrug-resistant CTX-M extended spectrum beta-lactamase-producing Escherichia coli from different bovine faeces in China
por: Wei, Xiaojuan, et al.
Publicado: (2023)

Molecular Basis for the Catalytic Specificity of the CTX-M Extended-Spectrum β-Lactamases
por: Adamski, Carolyn J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5dna0juj9b1jtng2gjeg005p7k